These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 25448602)

  • 1. Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortex.
    Walker DG; Whetzel AM; Serrano G; Sue LI; Beach TG; Lue LF
    Neurobiol Aging; 2015 Feb; 36(2):571-82. PubMed ID: 25448602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta.
    Griciuc A; Serrano-Pozo A; Parrado AR; Lesinski AN; Asselin CN; Mullin K; Hooli B; Choi SH; Hyman BT; Tanzi RE
    Neuron; 2013 May; 78(4):631-43. PubMed ID: 23623698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human brain sialoglycan ligand for CD33, a microglial inhibitory Siglec implicated in Alzheimer's disease.
    Gonzalez-Gil A; Porell RN; Fernandes SM; Maenpaa E; Li TA; Li T; Wong PC; Aoki K; Tiemeyer M; Yu ZJ; Orsburn BC; Bumpus NN; Matthews RT; Schnaar RL
    J Biol Chem; 2022 Jun; 298(6):101960. PubMed ID: 35452678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of CD33 rs3865444:C˃A polymorphism with a reduced risk of late-onset Alzheimer's disease in Slovaks is limited to subjects carrying the APOE ε4 allele.
    Javor J; Ďurmanová V; Párnická Z; Minárik G; Králová M; Pečeňák J; Vašečková B; Režnáková V; Šutovský S; Gmitterová K; Hromádka T; Peterajová Ľ; Shawkatová I
    Int J Immunogenet; 2020 Oct; 47(5):397-405. PubMed ID: 32333488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD33 Alzheimer's risk-altering polymorphism, CD33 expression, and exon 2 splicing.
    Malik M; Simpson JF; Parikh I; Wilfred BR; Fardo DW; Nelson PT; Estus S
    J Neurosci; 2013 Aug; 33(33):13320-5. PubMed ID: 23946390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the CD33 rs3865444 Polymorphism Confer Susceptibility to Alzheimer's Disease?
    Siokas V; Aslanidou P; Aloizou AM; Peristeri E; Stamati P; Liampas I; Arseniou S; Drakoulis N; Aschner M; Tsatsakis A; Mitsias PD; Bogdanos DP; Hadjigeorgiou GM; Dardiotis E
    J Mol Neurosci; 2020 Jun; 70(6):851-860. PubMed ID: 32088842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD33 in Alzheimer's disease.
    Jiang T; Yu JT; Hu N; Tan MS; Zhu XC; Tan L
    Mol Neurobiol; 2014 Feb; 49(1):529-35. PubMed ID: 23982747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics of CD33 in Alzheimer's disease and acute myeloid leukemia.
    Malik M; Chiles J; Xi HS; Medway C; Simpson J; Potluri S; Howard D; Liang Y; Paumi CM; Mukherjee S; Crane P; Younkin S; Fardo DW; Estus S
    Hum Mol Genet; 2015 Jun; 24(12):3557-70. PubMed ID: 25762156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Alzheimer's disease-protective CD33 splice variant mediates adaptive loss of function via diversion to an intracellular pool.
    Siddiqui SS; Springer SA; Verhagen A; Sundaramurthy V; Alisson-Silva F; Jiang W; Ghosh P; Varki A
    J Biol Chem; 2017 Sep; 292(37):15312-15320. PubMed ID: 28747436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD33 mRNA Has Elevated Expression Levels in the Leukocytes of Peripheral Blood in Patients with Late-Onset Alzheimer's Disease.
    Heidari F; Ansstas G; Ajamian F
    Gerontology; 2022; 68(4):421-430. PubMed ID: 34569532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy for Alzheimer's disease targeting CD33 reduces amyloid beta accumulation and neuroinflammation.
    Griciuc A; Federico AN; Natasan J; Forte AM; McGinty D; Nguyen H; Volak A; LeRoy S; Gandhi S; Lerner EP; Hudry E; Tanzi RE; Maguire CA
    Hum Mol Genet; 2020 Oct; 29(17):2920-2935. PubMed ID: 32803224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD33 and SHP-1/
    Beckers L; Rashid M; Lee AJ; Chatila ZK; Tamucci KA; Talcoff RC; Hall JL; Bennett DA; Vardarajan BN; Bradshaw EM
    Genes (Basel); 2024 Sep; 15(9):. PubMed ID: 39336795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease associated isoforms of human CD33 distinctively modulate microglial cell responses in 5XFAD mice.
    Eskandari-Sedighi G; Crichton M; Zia S; Gomez-Cardona E; Cortez LM; Patel ZH; Takahashi-Yamashiro K; St Laurent CD; Sidhu G; Sarkar S; Aghanya V; Sim VL; Tan Q; Julien O; Plemel JR; Macauley MS
    Mol Neurodegener; 2024 May; 19(1):42. PubMed ID: 38802940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of CD33 as a genetic risk factor for Alzheimer's disease.
    Estus S; Shaw BC; Devanney N; Katsumata Y; Press EE; Fardo DW
    Acta Neuropathol; 2019 Aug; 138(2):187-199. PubMed ID: 30949760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer's Disease.
    Griciuc A; Patel S; Federico AN; Choi SH; Innes BJ; Oram MK; Cereghetti G; McGinty D; Anselmo A; Sadreyev RI; Hickman SE; El Khoury J; Colonna M; Tanzi RE
    Neuron; 2019 Sep; 103(5):820-835.e7. PubMed ID: 31301936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD33 rs2455069 SNP: Correlation with Alzheimer's Disease and Hypothesis of Functional Role.
    Tortora F; Rendina A; Angiolillo A; Di Costanzo A; Aniello F; Donizetti A; Febbraio F; Vitale E
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validating GWAS Variants from Microglial Genes Implicated in Alzheimer's Disease.
    Dos Santos LR; Pimassoni LHS; Sena GGS; Camporez D; Belcavello L; Trancozo M; Morelato RL; Errera FIV; Bueno MRP; de Paula F
    J Mol Neurosci; 2017 Jun; 62(2):215-221. PubMed ID: 28477215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of Alzheimer's disease-associated CD33 results in an inflammatory human microglia phenotype.
    Wißfeld J; Nozaki I; Mathews M; Raschka T; Ebeling C; Hornung V; Brüstle O; Neumann H
    Glia; 2021 Jun; 69(6):1393-1412. PubMed ID: 33539598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD33: increased inclusion of exon 2 implicates the Ig V-set domain in Alzheimer's disease susceptibility.
    Raj T; Ryan KJ; Replogle JM; Chibnik LB; Rosenkrantz L; Tang A; Rothamel K; Stranger BE; Bennett DA; Evans DA; De Jager PL; Bradshaw EM
    Hum Mol Genet; 2014 May; 23(10):2729-36. PubMed ID: 24381305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SRSF1 and PTBP1 Are
    van Bergeijk P; Seneviratne U; Aparicio-Prat E; Stanton R; Hasson SA
    Mol Cell Biol; 2019 Sep; 39(18):. PubMed ID: 31208978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.